Indications for thrombolytic therapy in acute pulmonary embolism.

about

Timely embolectomy in acute massive pulmonary embolism prevents catastrophe: An experience from two cases.Use of Tachycardia in Patients With Submassive Pulmonary Emboli to Risk Stratify for Early Initiation of Thrombolytic Therapy: A Case Series Comparing Early Versus Late Thrombolytic Initiation.

P2860

Q37068195-072EB5E2-4327-4757-B7F1-E805B0601B00 Q47133264-5F728D34-24DE-40D1-AB68-5F09FEB33106

P2860

Indications for thrombolytic therapy in acute pulmonary embolism.

Item

http://www.wikidata.org/entity/Q35640900

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

1989年论文

@zh

1989年论文

@zh-cn

name

Indications for thrombolytic therapy in acute pulmonary embolism.

@ast

Indications for thrombolytic therapy in acute pulmonary embolism.

@en

type

Item

label

Indications for thrombolytic therapy in acute pulmonary embolism.

@ast

Indications for thrombolytic therapy in acute pulmonary embolism.

@en

prefLabel

Indications for thrombolytic therapy in acute pulmonary embolism.

@ast

Indications for thrombolytic therapy in acute pulmonary embolism.

@en

P1476

Indications for thrombolytic therapy in acute pulmonary embolism.

@en

P2093

J A Dieck

http://www.w3.org/2001/XMLSchema#string

J J Ferguson

http://www.w3.org/2001/XMLSchema#string

P2860

THE PHYSIOLOGY OF MASSIVE PULMONARY EMBOLISM: AN EXPERIMENTAL STUDY OF THE CHANGES PRODUCED BY OBSTRUCTION TO THE FLOW OF BLOOD THROUGH THE PULMONARY ARTERY AND ITS LOBAR BRANCHES

The hypercoagulable states.

Cardiopulmonary function in patients with pulmonary hypertension.

Natural history of pulmonary embolism.

Modification by beta-adrenergic blockade of the circulatory respones to acute hypoxia in man.

Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data.

Long-term prognosis of treated acute massive pulmonary embolism.

Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.

Pulmonary hypertension from chronic pulmonary thromboembolism.

Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism--can death from pulmonary embolism be prevented?

P304

19-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1989-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15227232

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

324838

http://www.w3.org/2001/XMLSchema#string

Indications for thrombolytic therapy in acute pulmonary embolism.

about

P2860

P2860

Indications for thrombolytic therapy in acute pulmonary embolism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932